Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Hangzhou AGS MedTech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,900	4,810	7,223	-	-	-
Market Cap Growth	4.84%	-33.41%	-	-	-	-
Enterprise Value	3,161	2,723	5,252	-	-	-
Last Close Price	60.70	58.43	85.62	-	-	-
PE Ratio	18.01	16.39	33.25	-	-	-
Forward PE	15.14	15.01	-	-	-	-
PS Ratio	7.33	7.56	14.20	-	-	-
PB Ratio	1.97	2.01	3.27	-	-	-
P/TBV Ratio	1.98	2.02	3.30	-	-	-
P/FCF Ratio	32.76	18.07	42.52	-	-	-
P/OCF Ratio	22.39	15.23	32.62	-	-	-
EV/Sales Ratio	4.73	4.28	10.32	-	-	-
EV/EBITDA Ratio	11.58	9.39	23.31	-	-	-
EV/EBIT Ratio	12.01	9.65	24.01	-	-	-
EV/FCF Ratio	21.14	10.23	30.92	-	-	-
Debt / Equity Ratio	0.00	0.00	0	0.00	0.01	-
Debt / EBITDA Ratio	0.01	0.01	0.00	0.01	0.02	-
Debt / FCF Ratio	0.02	0.01	0.00	0.02	0.02	-
Net Debt / Equity Ratio	-0.70	-0.74	-0.92	-0.70	-0.75	-0.72
Net Debt / EBITDA Ratio	-6.39	-6.14	-9.04	-1.72	-1.68	-3.08
Net Debt / FCF Ratio	-11.62	-6.69	-11.99	-2.77	-1.98	-6.20
Asset Turnover	0.27	0.26	0.36	0.91	1.01	0.72
Inventory Turnover	3.22	3.51	3.51	3.04	3.62	3.31
Quick Ratio	18.22	12.91	17.37	3.18	3.19	3.90
Current Ratio	18.93	13.34	17.78	3.65	3.81	4.43
Return on Equity (ROE)	11.41%	12.74%	16.78%	44.40%	42.94%	23.30%
Return on Assets (ROA)	6.57%	7.22%	9.75%	23.02%	24.30%	12.33%
Return on Invested Capital (ROIC)	33.12%	61.09%	131.83%	143.69%	155.62%	89.30%
Return on Capital Employed (ROCE)	10.50%	11.70%	9.90%	39.30%	42.90%	21.80%
Earnings Yield	5.57%	6.10%	3.01%	-	-	-
FCF Yield	3.05%	5.54%	2.35%	-	-	-
Dividend Yield	2.26%	2.35%	1.21%	-	-	-
Payout Ratio	40.74%	28.40%	20.25%	24.80%	46.80%	-
Buyback Yield / Dilution	-0.35%	-11.02%	-19.46%	0.00%	-	0.10%
Total Shareholder Return	1.91%	-8.67%	-18.25%	-	-	0.10%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.